AIRO Group Holdings, Inc. Common Stock
NASDAQ:AIROAerospace & Defense
+$0.43 today
- Market cap
- $141.13M
- Beta
- 1.82
- P/E (TTM)
- -14.2
- EPS (TTM)
- -$0.56
Volume 0.28M
Average 0.62M
AIRO Revenue
Total income from selling goods and services before any costs are deducted; the top line of the income statement.
AIRO Group Holdings, Inc. Common StockNASDAQ: AIRO
Revenue · Q1 FY2026 · quarter ended Mar 2026
Revenue dips below year-ago levels
Q1 FY2026 revenue of $8.9M fell 24.5% year over year, behind the +3.6% change in trailing-twelve-month revenue. Sequentially, it fell 81.6% from the prior quarter. Over 3 fiscal years it compounded at +74.6% a year.
Context
- Revenue increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether revenue reaches the consensus estimate from 2 analysts of $108.31M (+19.1%) for the fiscal year ending Dec 2026, a step up from the +4.6% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $8.9M-81.6% QoQ
- Last fiscal yearDec 2025
- $90.91M+4.6% YoY
- LTMMar 2026
- $88.01M+3.6% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -24.5% | +26.9% | +51.4 pp |
| 1 year | +4.6% | +19.1% | +14.6 pp |
| 3-year CAGR | +74.6% | +44.2% | -30.4 pp |
| 5-year CAGR | +34.1% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Revenue history
USD · from the income statement
- Latest · FY2025
- 90.91M USD
- Year-over-year change
- +4.6%
- 4-year CAGR
- +66.7%
| Period | Period end | Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 90.91M | +4.6% |
| FY2024 | 2024-12-31 | 86.94M | +101.0% |
| FY2023 | 2023-12-31 | 43.25M | +153.2% |
| FY2022 | 2022-12-31 | 17.08M | +45.0% |
| FY2021 | 2021-12-31 | 11.78M | — |
Revenue vs competitors
How AIRO compares with its peers on the latest reported figures
- Peers report in different currencies, so revenue is compared through growth and rates rather than absolute size.
- Its year-over-year change of +3.6% is the 5th highest of 10, against a peer median of +1.1%.
- Over three fiscal years its annual growth of +74.6% compares with a peer median of +2.8%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | $1.85B USD | -8.2% | +2.2% | |
| LTM Mar 2026 | $845.48M USD | +13.9% | +2.8% | |
| LTM Apr 2026 | $523.85M USD | +10.4% | +3.0% | |
| LTM Mar 2026 | $446.43M USD | -3.3% | -20.8% | |
| LTM Feb 2026 | $392.4M USD | -0.6% | -3.1% | |
SRTAStrata Critical Medical, Inc. | LTM Mar 2026 | $254.27M USD | +1.1% | +10.5% |
| LTM Mar 2026 | $182.94M USD | -7.1% | -7.5% | |
| LTM Feb 2026 | $120.98M USD | +27.0% | +35.0% | |
| LTM Mar 2026 | $88.01M USD | +3.6% | +74.6% | |
| LTM Mar 2026 | $73.3M USD | +18.2% | +10.7% | |
| LTM Mar 2026 | £0 GBP | — | — | |
| Peer median (excluding AIRO) | — | +1.1% | +2.8% | |
Competitors are the stored peer set for AIRO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 11.78M | 17.08M | 43.25M | 86.94M | 90.91M |
| Cost of Revenue | 8.3M | 12.95M | 18.34M | 28.62M | 36.49M |
| Gross Profit | 3.48M | 4.13M | 24.91M | 58.32M | 54.42M |
| Gross Margin | 29.5% | 24.2% | 57.6% | 67.1% | 59.9% |
| Research & Development | 1.15M | 9.3M | 11.87M | 13.13M | 17.92M |
| Selling, General & Admin | 4.9M | 21.83M | 22.98M | 24.62M | 65.26M |
| Operating Expenses | 6.05M | 31.13M | 34.85M | 75.75M | 83.18M |
| Depreciation & Amortization | 1.05M | 10.05M | 13.25M | 12.99M | 12.59M |
| EBITDA | (16.07M) | (23.1M) | (14.78M) | (2.27M) | 25.33M |
| EBITDA Margin | -136.4% | -135.2% | -34.2% | -2.6% | 27.9% |
| Operating Income | (2.57M) | (27M) | (9.93M) | (17.43M) | (28.77M) |
| Operating Margin | -21.8% | -158.1% | -23.0% | -20.1% | -31.6% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 3.39M | 3.62M | 2.14M | 14.23M | 9.8M |
| Other Income / Expenses | (17.94M) | (9.76M) | (20.23M) | (12.05M) | 31.7M |
| Income Before Tax | (20.52M) | (36.76M) | (30.16M) | (29.49M) | 2.94M |
| Pre-Tax Margin | -174.1% | -215.2% | -69.7% | -33.9% | 3.2% |
| Income Tax Expense | 12.85K | (11.21M) | 2.29M | 9.21M | 7.04M |
| Net Income | (20.53M) | (25.55M) | (32.46M) | (38.69M) | (4.1M) |
| Net Margin | -174.2% | -149.6% | -75.0% | -44.5% | -4.5% |
| EPS (Basic) | (0.82) | (1.03) | (1.30) | (1.55) | (0.17) |
| EPS (Diluted) | (0.82) | (1.03) | (1.30) | (1.55) | (0.17) |
| Weighted Avg Shares | 24.89M | 24.89M | 24.89M | 24.89M | 23.68M |
| Weighted Avg Shares (Diluted) | 24.89M | 24.89M | 24.89M | 24.89M | 23.68M |
AIRO Group Holdings, Inc. Common Stock
NASDAQ:AIRO
Intrinsic Alpha fair value
Locked
Current Price
$4.43
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.